HLAクラスI欠乏症における同位体のヒトTAPペプチドトランスポーター変異
H de la Salle1, D Hanau, D Fricker
1Laboratoire d'Histocompatibilité, Centre Régional de Transfusion Sanguine, Strasbourg, France.
まとめ
抗原処理 (TAP) タンパク質に関連するトランスポーターの遺伝的欠陥は,ヒト白血球抗原 (HLA) クラスI発現を阻害し,再発性感染症と変化したT細胞集団につながります. これは,自然殺人細胞の細胞毒性および適応免疫反応に影響します.
科学分野:
- 免疫学 免疫学とは
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- ヒト白血球抗原 (HLA) クラスIの発現は,適応免疫にとって極めて重要です.
- HLAクラスI分子は,T細胞にペプチドを提示し,これは抗原処理 (TAP) に関連するトランスポーターに依存するプロセスです.
- TAPの欠乏は,免疫系の機能不全につながる可能性があります.
研究 の 目的:
- 抗原処理 (TAP) 欠乏症に関連する遺伝トランスポーターの免疫学的影響を調査する.
- TAP欠乏症の個体における免疫細胞のプロファイルと機能を特徴付ける.
主な方法:
- 細胞表面タンパク質発現の分析 (HLAクラスI,CD1a).
- 自然キラー (NK) 細胞の細胞毒性の評価.
- T細胞サブセット (CD8+アルファベータT細胞,CD4+CD8+T細胞,ガンマデルタT細胞) を定量化するためのフローサイトメトリ.
主要な成果:
- ヒト白血球抗原 (HLA) クラスIタンパク質の細胞表面表現が著しく低下した.
- 正常なCD1a発現と,影響を受けた自然キラー (NK) 細胞の細胞毒性.
- 細胞毒性CD8+アルファベータT細胞の少ないが有意な数が検出されました.
- 最も影響を受けた兄弟のCD4+CD8+およびガンマデルタT細胞の増加.
結論:
- 抗原処理 (TAP) 欠乏に関連した遺伝トランスポーターは,ヒト白血球抗原 (HLA) クラスIプレゼンテーションに深刻に影響を与えます.
- TAP欠乏症は,再発する細菌感染症とT細胞の恒常性の変化につながる.
- この研究は,適応性および先天性免疫におけるTAPの重要な役割を強調しています.
関連する概念動画
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


